arrow
R

Rosalba Minisini

Università del Piemonte Orientale
H指数:31
被引数:3,089

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Extracellular Vesicles as a Potential Biomarker of Pulmonary Arterial Hypertension in Systemic Sclerosis
2025-02-141
OAAI
Lower Circulating Gas6 Levels Are Associated with Bulbar Phenotype and Faster Disease Progression in Amyotrophic Lateral Sclerosis Patients

低循环气体6水平与延髓症状及肌萎缩侧索硬化症患者疾病进展加速相关

2025-01-060
PRE
Chronic Hepatitis C Infection Treated with Direct-Acting Antiviral Agents and Occurrence/Recurrence of Hepatocellular Carcinoma: Does It Still Matter?
2024-12-100
OAAI
Delivering adjuvant and neoadjuvant treatments in the early stages of hepatocellular carcinoma

在肝细胞癌的早期阶段提供辅助和新辅助治疗

2024-10-223
OAAI
Mechanisms of Resistance to Immunotherapy in Hepatocellular Carcinoma

肝细胞癌免疫治疗耐药机制的研究进展

2023-11-017
OAAI
SARS-CoV-2 infection risk is higher in vaccinated patients with inflammatory autoimmune diseases or liver transplantation treated with mycophenolate due to an impaired antiviral immune response: results of the extended follow up of the RIVALSA prospective cohort

由于抗病毒免疫反应受损,炎症性自身免疫性疾病或接受霉酚酸酯治疗的肝移植患者的SARS-CoV-2感染风险更高: RIVALSA前瞻性队列的扩展随访结果

2023-07-206
OAAI
Inflammatory and Immune Responses during SARS-CoV-2 Infection in Vaccinated and Non-Vaccinated Pregnant Women and Their Newborns

接种疫苗和未接种疫苗的孕妇及其新生儿在SARS-CoV-2感染期间的炎症和免疫反应

2023-04-293
OAAI
Effect of Lactoferrin on Clinical Outcomes of Hospitalized Patients with COVID-19: The LAC Randomized Clinical Trial
2023-03-0415
OAAI
Baseline Plasma Osteopontin Protein Elevation Predicts Adverse Outcomes in Hospitalized COVID-19 Patients
2023-02-259
OAAI
Determinants of long COVID among adults hospitalized for SARS-CoV-2 infection: A prospective cohort study
2022-12-1923
OAAI
CGRP Plasma Levels Correlate with the Clinical Evolution and Prognosis of Hospitalized Acute COVID-19 Patients
2022-09-2612
OAAI
Ongoing Mycophenolate Treatment Impairs Anti-SARS-CoV-2 Vaccination Response in Patients Affected by Chronic Inflammatory Autoimmune Diseases or Liver Transplantation Recipients: Results of the RIVALSA Prospective Cohort

正在进行的霉酚酸酯治疗削弱了慢性炎症性自身免疫性疾病或肝移植受者的Anti-SARS-CoV-2疫苗接种反应: RIVALSA前瞻性队列的结果

2022-08-1217
OAAI